Sectors
MSLE
Satellos Bioscience Inc.
8.82
1 x 10.20
1 x 10.15
bid
ask
-
0.06
0.73%
10:00 AM
timesize
| Ytd | 50.00% | |
| 1y | 68.97% |
8.68
day range
9.18
5.30
52 week range
13.39
| Open | 8.78 | Prev Close | 8.88 | Low | 8.68 | High | 9.18 | Mkt Cap | 187.13M |
| Vol | 6.88K | Avg Vol | 54.12K | EPS | -1.95 | P/E | N/A | Forward P/E | N/A |
| Beta | 1.51 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 8.93 | 200-d Avg | 8.05 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 12.17M | ||
| Research and Development Expense | 9.64M | ||
| Selling, General and Administrative Expense | 2.53M | ||
| Operating Income | -12.16M | ||
| Income Tax Expense | 44.00K | ||
| Net Income | -11.72M | ||
| Net Income Common Stock | -11.72M | ||
| Net Income Common Stock (USD) | -11.72M | ||
| Consolidated Income | -11.72M | ||
| Earnings per Basic Share | -0.56 | ||
| Earnings per Basic Share (USD) | -0.56 | ||
| Earnings per Diluted Share | -0.56 | ||
| Earning Before Interest & Taxes (EBIT) | -11.67M | ||
| Earning Before Interest & Taxes (USD) | -11.67M | ||
| Weighted Average Shares | 20.83M | ||
| Weighted Average Shares Diluted | 20.83M | ||
| Balance Sheet | |||
| Cash and Equivalents | 7.39M | ||
| Cash and Equivalents (USD) | 7.39M | ||
| Investments | 54.45M | ||
| Investments Current | 54.45M | ||
| Current Assets | 65.76M | ||
| Property, Plant & Equipment Net | 7.00K | ||
| Total Assets | 65.77M | ||
| Current Liabilities | 5.86M | ||
| Total Liabilities | 5.86M | ||
| Accumulated Retained Earnings (Deficit) | -103.46M | ||
| Accumulated Other Comprehensive Income | -1.70M | ||
| Shareholders Equity | 59.91M | ||
| Shareholders Equity (USD) | 59.91M | ||
| Assets Non-Current | 7.00K | ||
| Trade and Non-Trade Payables | 5.86M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1000 | ||
| Net Cash Flow from Financing | 37.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -11.30M | ||
| Issuance (Purchase) of Equity Shares | 37.00K | ||
| Net Cash Flow from Investing | -3.34M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -3.34M | ||
| Net Cash Flow from Operations | -8.03M | ||
| Effect of Exchange Rate Changes on Cash | 27.00K | ||
| Share Based Compensation | 922.00K | ||